Pages


Wednesday, November 16, 2022

I'm gonna take a hard pass on that one too

Pfizer and BioNTech said Friday that the immune responses against omicron BA.4/BA.5 subvariants were "substantially higher" in people who got its new bivalent booster compared with people who received the companies' original COVID-19 vaccine.